Since FBLN3, IBP5, IBP7, and PDGFD play oncogenic roles through the regulation of tumor cell growth, invasion, metastasis, EMT, and CSCs, targeting these proteins, their receptors, or downstream signaling pathways could be valuable strategies to interfere with stromal-cancer cell heterotypic communication. This evidence concerns the gene IGFBP5 and neoplasm.